«Biotech and Life Extension»
with Amber Wigmore Álvarez
Executive Director of Career Services
You don’t need top-level knowledge on Biotech to perceive that this industry is changing our well-being, life extension and age management. Many questions buzz around Biotech: How has our life expectancy changed in the past century? How will it shift during the next one? Will we be living to be 120 years? 200? Is there a limit? And in this hypothetical panorama, what will happen to our careers? Will we live to pursue 70-year careers? Will we educate and renovate ourselves every couple of decades or so to pursue new ones? What is going to happen to “early retirement”? Will this even exist? And at what age? What is early? We might not have the answer to these, however Yessica Fernández-Cruz and Bosco Emparanza, our two guest experts from the industry, along with my co-host William Dávila and me, have helped shed some light on what is being done and how Biotech is consolidating into a strategic industry today.
Don’t miss out on what the experts have to say and listen to the podcast now.
Stay tuned for the next monthly Career Journeys live radio show on October 25, 2016 at Vaughan Radio.
Listen to my previous podcasts in iVooxGo to iVOOX
More about the speakers:
Director of Corporate Relations at IE Business School
"There is a big revolution around aging. Is there a limit to life expectancy? Will it be 120 years? Will it be 200 years?"
Sales & Marketing Director at Life Length
"The booming careers are the STEMs: Science, Technology, Engineering and Mathematics. These are always going to be necessary in Biotechnology. The core of Biotech is research and development so, of course, science will be key. Now we're finding more and more people with a mix of a scientific and a business background."
Co-founder of Biotech Services